MIS Sacroiliac Joint Fusion Market Analysis

MIS Sacroiliac Joint Fusion Market Analysis

To get key market trends

  Download Free Sample

Based on product, the MIS sacroiliac joint fusion market is segmented as implants and instruments & equipment. The implants segment dominates the market share in 2022 and is anticipated to crossed USD 458 million. The use of implants in minimally invasive sacroiliac joint fusion is offering several advantages over traditional open surgical techniques. Implants used in MIS SI joint fusion are typically designed to facilitate accurate and controlled placement. This helps ensure proper alignment and fixation of the joint, promoting successful fusion and reducing the risk of complications.
 

The use of implants in MIS SI joint fusion minimizes disruption to the surrounding soft tissues by utilizing minimally invasive techniques and smaller incisions. This can lead to less postoperative pain, reduced muscle damage, and a faster return to normal activities. Thus, the specific advantages of implants used in MIS SI joint fusion will accelerate the product demand. 
 

Based on approach, the MIS sacroiliac joint fusion market is segmented as dorsal and anterior. The dorsal segment acquired dominant market share in 2022 and was worth over USD 413 million. The dorsal (posterior) approach in minimally invasive sacroiliac joint (SIJ) fusion offers several advantages compared to other approaches. The dorsal approach provides direct access to the posterior aspect of the SIJ, that is the target area for fusion. This allows precise placement of implants and facilitates complete joint reconstruction. The dorsal approach avoids manipulation or disruption of vital structures such as major blood vessels, nerves, and the bowel. This reduces the risk of complications associated with injury to these structures. As a result, several advantages associated with the dorsal approach will augment the market growth.
 

Based on indication, the MIS sacroiliac joint fusion market is segmented as trauma, degenerative sacroiliitis, and sacroiliac joint dysfunction. The degenerative sacroiliitis segment accounted major market share in 2022 and reached around USD 392 million. Sacroiliac joint fusion is a surgical procedure widely used to treat degenerative sacroiliitis. Degenerative sacroiliitis can cause chronic pain and discomfort in the lower back, buttocks, and legs. MIS sacroiliac joint fusion is a minimally invasive approach that aims to stabilize the sacroiliac joint and reduce pain.
 

By fusing the sacroiliac joint, the procedure aims to reduce the motion in the joint that can help alleviate pain and improve overall stability. The fusion allows the two bones to heal together over time, forming a solid, immobile connection. As a result, the painful movement and inflammation associated with the degenerated joint are minimized.
 

Based on end-use, the MIS sacroiliac joint fusion market is segmented as hospitals, ambulatory surgical centers, and others. The hospitals segment captured the market in 2022 and is projected to exceed USD 1.13 billion by 2032. Hospital healthcare facilities offer several advantages in the management of sacroiliac joint fusion. Hospitals typically have well-established infrastructure and resources to support complex medical procedures comprising sacroiliac joint fusion. They have state-of-the-art operating rooms, specialized equipment, and a range of healthcare professionals to provide comprehensive care. They may have advanced imaging modalities, computer-assisted navigation systems, and other innovative tools that can enhance the precision and safety of the sacroiliac joint fusion procedure.
 

U.S. held a dominant share in the North America MIS sacroiliac joint fusion market and is set to reach USD 749 million by 2032. North America including the U.S. is one of the major markets for MIS sacroiliac joint fusion. The region has a well-established healthcare infrastructure, a large patient population, and a high prevalence of chronic lower back pain that often includes sacroiliac joint dysfunction. Healthcare professionals in the U.S. may become more confident in recommending the procedure to their patients, as more clinical evidence is accumulated regarding the effectiveness & safety of sacroiliac joint fusion.
 

As the population ages, the incidence of degenerative conditions & chronic pain including sacroiliac joint dysfunction is expected to increase in the coming years. This may drive the demand for sacroiliac joint fusion procedures.